Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Salvi

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Clinical Immunology (Orlando, Fla.)|February 7, 2009
Rituximab treatment in a patient with severe thyroid-associated ophthalmopathy: effects on orbital lymphocytic infiltratesMario Salvi, Guia Vannucchi, Irene Campi, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|January 11, 2012
Small dose of rituximab for graves orbitopathy: new insights into the mechanism of actionMario Salvi, Guia Vannucchi, Nicola Currò, et al.
Thyroid : Official Journal of the American Thyroid Association|July 28, 2015
B Cell Activating Factor (BAFF) and BAFF Receptor Expression in Autoimmune and Nonautoimmune Thyroid DiseasesIrene Campi, Delfina Tosi, Stefania Rossi, et al.
European Thyroid Journal|January 30, 2023
Long-term outcome of thyroid abnormalities in patients with severe Covid-19Ilaria Muller, Anita Daturi, Matteo Varallo, et al.
Thyroid : Official Journal of the American Thyroid Association|May 4, 2023
Clinical and Visual Outcomes of Dysthyroid Optic Neuropathy After Surgical Orbital DecompressionNicola Currò, Claudio Guastella, Giacinta Pirola, et al.
The Lancet. Diabetes & Endocrinology|August 3, 2020
SARS-CoV-2-related atypical thyroiditisIlaria Muller, Daniele Cannavaro, Davide Dazzi, et al.
Clinical Immunology (Orlando, Fla.)|July 14, 2023
SARS-COV-2 specific t-cells in patients with thyroid disorders related to COVID-19 are enriched in the thyroid and acquire a tissue-resident memory phenotypeYlenia Silvestri, Francesca Clemente, Giorgia Moschetti, et al.
The Journal of Clinical Endocrinology and Metabolism|January 23, 2023
Gut Microbiome Associated With Graves Disease and Graves Orbitopathy: The INDIGO Multicenter European StudyFilippo Biscarini, Giulia Masetti, Ilaria Muller, et al.
The Lancet. Diabetes & Endocrinology|February 4, 2018
Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trialGeorge J Kahaly, Michaela Riedl, Jochem König, et al.
Thyroid : Official Journal of the American Thyroid Association|September 12, 2015
Future Research in Graves' Orbitopathy: From Priority Setting to Trial Design Through Patient and Public InvolvementPetros Perros, Colin M Dayan, A Jane Dickinson, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Clinical Immunology (Orlando, Fla.)|February 7, 2009
Rituximab treatment in a patient with severe thyroid-associated ophthalmopathy: effects on orbital lymphocytic infiltratesMario Salvi, Guia Vannucchi, Irene Campi, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|January 11, 2012
Small dose of rituximab for graves orbitopathy: new insights into the mechanism of actionMario Salvi, Guia Vannucchi, Nicola Currò, et al.
Thyroid : Official Journal of the American Thyroid Association|July 28, 2015
B Cell Activating Factor (BAFF) and BAFF Receptor Expression in Autoimmune and Nonautoimmune Thyroid DiseasesIrene Campi, Delfina Tosi, Stefania Rossi, et al.
European Thyroid Journal|January 30, 2023
Long-term outcome of thyroid abnormalities in patients with severe Covid-19Ilaria Muller, Anita Daturi, Matteo Varallo, et al.
Thyroid : Official Journal of the American Thyroid Association|May 4, 2023
Clinical and Visual Outcomes of Dysthyroid Optic Neuropathy After Surgical Orbital DecompressionNicola Currò, Claudio Guastella, Giacinta Pirola, et al.
The Lancet. Diabetes & Endocrinology|August 3, 2020
SARS-CoV-2-related atypical thyroiditisIlaria Muller, Daniele Cannavaro, Davide Dazzi, et al.
Clinical Immunology (Orlando, Fla.)|July 14, 2023
SARS-COV-2 specific t-cells in patients with thyroid disorders related to COVID-19 are enriched in the thyroid and acquire a tissue-resident memory phenotypeYlenia Silvestri, Francesca Clemente, Giorgia Moschetti, et al.
The Journal of Clinical Endocrinology and Metabolism|January 23, 2023
Gut Microbiome Associated With Graves Disease and Graves Orbitopathy: The INDIGO Multicenter European StudyFilippo Biscarini, Giulia Masetti, Ilaria Muller, et al.
The Lancet. Diabetes & Endocrinology|February 4, 2018
Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trialGeorge J Kahaly, Michaela Riedl, Jochem König, et al.
Thyroid : Official Journal of the American Thyroid Association|September 12, 2015
Future Research in Graves' Orbitopathy: From Priority Setting to Trial Design Through Patient and Public InvolvementPetros Perros, Colin M Dayan, A Jane Dickinson, et al.
Pageof 6